Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Broadleaf, Last Fiscal Year's Net Income Exceeds Expectations, 2.9 times Increase in Net Income for The Current Fiscal Year, Dividend Raised by 2 yen
3673 Broadleaf Co.,Ltd. 【IFRS】
Earnings ReportBroadleaf Co.,Ltd. <3673> [TSE Prime] announced its financial results (based on IFRS) after the market closed on February 7th (15:30). The consolidated net income/loss for the fiscal year ending December 2024 turned into a profit of 0.34 billion yen (compared to a loss of 1.48 billion yen in the previous period), exceeding the previous forecast of 0.12 billion yen. In the fiscal year ending December 2025, the consolidated net income is expected to surge 2.9 times the previous term, reaching 1 billion yen.
At the same time, the company has decided to significantly increase the dividend this fiscal year to 4 yen, an increase of 2 yen from the previous fiscal year.
In the most recent three-month period, from October to December (4Q), the consolidated net income/loss turned to a profit of 0.18 billion yen (compared to a loss of 0.45 billion yen in the same period last year). The operating profit/loss margin drastically improved from -9.2% in the same period last year to 7.6%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2022 | 13,833 | -2,897 | -3,005 | -2,431 | -27.5 | 1 | Feb 10, 2023 | IFRS |
Dec, 2023 | 15,385 | -1,902 | -1,921 | -1,487 | -16.8 | 1 | Feb 9, 2024 | IFRS |
Dec, 2024 | 18,045 | 674 | 545 | 343 | 3.9 | 2 | Feb 7, 2025 | IFRS |
YoY | +17.3% | - | - | - | - |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2024 Guidance | 17,800 | 450 | 350 | 125 | 1.4 | 2 | Nov 12, 2024 | IFRS |
Dec, 2024 Results | 18,045 | 674 | 545 | 343 | 3.9 | 2 | Feb 7, 2025 | IFRS |
Revision Rate | +1.4% | +49.8% | +55.7% | +174.4% | +175.0% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 8,421 | -44 | 16 | -14 | -0.2 | 0 | Aug 8, 2024 | IFRS |
Jan - Jun, 2025 Guidance | 9,500 | 300 | 300 | 200 | 2.2 | 2 | Feb 7, 2025 | IFRS |
YoY | +12.8% | - | +1,775.0% | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 15,385 | -1,902 | -1,921 | -1,487 | -16.8 | 1 | Feb 9, 2024 | IFRS |
Dec, 2024 | 18,045 | 674 | 545 | 343 | 3.9 | 2 | Feb 7, 2025 | IFRS |
Dec, 2025 Guidance | 20,100 | 1,500 | 1,500 | 1,000 | 11.2 | 4 | Feb 7, 2025 | IFRS |
YoY | +11.4% | +122.6% | +175.2% | +191.5% | +191.2% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 4,136 | -380 | -436 | -459 | -5.2 | -9.2 | Feb 9, 2024 | IFRS |
Jan - Mar, 2024 | 4,014 | -109 | -42 | -35 | -0.4 | -2.7 | May 9, 2024 | IFRS |
Apr - Jun, 2024 | 4,407 | 65 | 58 | 21 | 0.2 | 1.5 | Aug 8, 2024 | IFRS |
Jul - Sep, 2024 | 4,537 | 332 | 277 | 175 | 2.0 | 7.3 | Nov 12, 2024 | IFRS |
Oct - Dec, 2024 | 5,087 | 386 | 252 | 182 | 2.0 | 7.6 | Feb 7, 2025 | IFRS |
YoY | +23.0% | - | - | - | - |
Related Articles
Nissan Chemical, The Current Fiscal Year Ordinary Profit Revised Upward by 5%, Highest in Two Terms
Procrea Holdings, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 96%, Exceeds Full-Year Plan
TORII PHARMA, 35% Decrease in Ordinary Profit for The Current Fiscal Year
KAPPA CREATE, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 22%, Oct-Dec Ordinary Profit Decreases by 6%
RENAISSANCE INC, The Current Fiscal Year Ordinary Profit Revised Upward by 20%, Dividend Revised Upward by 1 yen
KYORITSU MAINTENANCE, The Current Fiscal Year Ordinary Profit Revised Upward to an Unexpected 2% Increase, Raises Record High Profit, Dividend Revised Upward by 4 yen
YUTAKA GIKEN, Apr-Dec (Cumulative 3Q) Net Income Decreases by 34%, Exceeds Full-Year Plan
SANSEI, Oct-Dec (3Q) Ordinary Profit Increases by 52%
DUSKIN, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 42%, Oct-Dec Ordinary Profit Increases by 55%
OKAMURA, Oct-Dec (3Q) Ordinary Profit Increases by 29%